[Mechanism of the antihypertensive activity of the oxazoline derivative BAY a 6781].
D000814:Aniline Compounds / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D006321:Heart / Q000187:drug effects; D007267:Injections; D007275:Injections, Intravenous; D009638:Norepinephrine / Q000378:metabolism; D010080:Oxazoles / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000187:drug effects
D000814:Aniline Compounds; D000959:Antihypertensive Agents; D010080:Oxazoles; D009638:Norepinephrine; D010646:Phentolamine
Zum Mechanismus der antihypertensiven Wirkung des Oxazolin-Derivates BAY a 6781.